In recent years, HULC has been found to be dysregulated in osteosarcoma, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, gastric cancer, hepatocellular carcinoma and large B-cell lymphoma [16–22]. This evidence concerns the gene HULC and hepatocellular carcinoma.